Cytoreductive Surgery
Peritoneal metastases (PM) from various tumors can now be effectively treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). However, this is a complicated treatment that is challenging to apply, and for excellent outcomes, careful patient selection is required. The purpose of cytoreductive surgery is to completely eradicate all macroscopic cancer. This is accomplished through peritonectomy procedures and, if necessary, en-bloc resection of the viscera. Using them depends on how severe the PM is. Only the damaged peritoneum is removed; the normal peritoneum is not removed.